Tag: Pharmaceutical Industry
Firms map out Sun Pharma’s USD11.75bn Organon acquisition
Firms guide Sun Pharmaceutical Industries, its subsidiaries and associate companies on the USD11.75 billion Organon acquisition
Unpacking China’s antitrust law regime
China tightens antitrust rules with AML reforms and stricter enforcement
A comparison of developments in healthtech
South Korea boosts drug development; Russia tackles telemedicine and data protection
IHCF appoints new leader in Seoul
IHCF names Australian lawyer with 16 years in global pharma as new president
BJContinent achieves first reverse US takeover under new rules
Gibson Dunn, Orrick, and DeHeng facilitate BJContinent's historic reverse US takeover under new rule
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Playing catch-up
Shared venture documentation gaps slow India funding rounds and shape foreign capital perceptions of ecosystem maturity
